Settings Today

Regeneron starts Phase 3 trial of Covid-19 antibody cocktail

An antibody cocktail is now beginning late-stage clinical trials to evaluate the drug's ability to prevent and treat coronavirus infection.

Published 1760 days ago

Go Back to Reading NewsBack Read News Collect this News Article

Login to Continue, We will bring you back to this content 0



For peering opportunity Autonomouse System Number: AS401345 Custom Software Development at ErnesTech Email Address[email protected]